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Human T-cell Lymphotropic Virus type-1 (HTLV-1) is
the causative agent of an aggressive malignancy of CD4
+ T lymphocytes. It is believed that the viral transactiva-
tor Tax-1 is a major player in T-cell transformation.
Thus, targeting Tax-1 protein is regarded as a possible
strategy to arrest viral replication and ultimately to
counteract neoplastic transformation.
Here, we demonstrated that CIITA, the master regula-
tor of MHC class II gene transcription, inhibits HTLV-1
replication by blocking the transactivating function of
Tax-1. Co-immunoprecipitation experiments have
shown that CIITA and Tax-1 physically interact in vivo
and that the first 108 amino acids of Tax-1 were neces-
sary for this binding. Two adjacent regions (1-252 and
253-410) of CIITA bound independently to Tax-1, but
only region 1-252 mediated Tax-1 inhibition, in agree-
ment with the fact that CIITA residues from positions
64-124 were required to block Tax-1 transactivation.
CIITA inhibitory action on Tax-1 function correlated
with the nuclear localization of CIITA and was indepen-
dent of the transcription factor NF-YB, previously
involved in CIITA-mediated inhibition of Tax-2 of
HTLV-2, a virus with still elusive pathogenic action.
Furthermore, CIITA severely impaired the physical and
functional interaction of Tax-1 with the cellular co-acti-
vator PCAF, which is required for the optimal activation
of HTLV-1 promoter. Accordingly, the over-expression
of PCAF restored Tax-1-dependent transactivation of
the viral LTR promoter inhibited by CIITA.
These findings strongly support our original observa-
tion that CIITA, beside increasing the antigen-present-
ing function for pathogen antigens, acts as an
endogenous restriction factor against human retro-
viruses by blocking virus replication and spreading.
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